We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Laboratories with More Automated, Fluid Workflow Need Better QC

By LabMedica International staff writers
Posted on 07 Jan 2010
The frequency of running quality control (QC) plays a major role in managing patient risk. More...
QC has been run on a time-based frequency due to a batch-based workflow--twice a day, three times a week, etc. However, today's laboratories have migrated from batch analysis to a more automated and fluid workflow; the standard practice of immediate result reporting has compounded the need for appropriate QC strategies so that the time between reporting a result and the next scheduled QC event is optimized.

The American Association for Clinical Chemistry (AACC; Washington DC, USA) announced that a 60-minute webinar would take place on customizing quality control for improved patient safety. It will be held on March 5, 2010, at 14:00 hours (EST).

The program will be supported, in part, by Bio-Rad Laboratories (Plano, TX, USA; www.biorad.com) and Siemens Healthcare Diagnostics (Walpole, MA, USA), and is directed towards members of the media.

Curtis A. Parvin, Ph.D., manager of advanced statistical research, quality systems division, Bio-Rad Laboratories will explain why the traditional batch-based QC practices are not good enough for today's workflow, how laboratories can customize QC practices to their workflow, what QC rules best determine that the laboratory's testing is still in control, and how to maximize patient safety in today's world of immediate result reporting. The program will be followed by a question and answer session.

For more information about the webinar or AACC, please contact Peter Patterson, professional affairs coordinator at AACC (please see related links below).

AACC is a leading professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations.

Related Links:

American Association of clinical chemistry
Bio-Rad Laboratories
Siemens Healthcare Diagnostics
Contact Mr. Peter Patterson



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.